Top Markets
Coin of the day
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Classifica tra le azioni #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Prezzo delle azioni
$0.84484795
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$892.08M
Variazione (1 giorno)
-4.11%
Variazione (1 anno)
27.37%
Paese
CN
Scambia Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Categoria

Rapporto P/B per Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Chongqing Lummy Pharmaceutical Co., Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Chongqing Lummy Pharmaceutical Co., Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
31.0864 -
US
7.4766 -
US
-74.4354 -
US
8.4776 -
CH
8.008 -
US